| Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic … M Clavel, JB Vermorken, F Cognetti, P Cappelaere, PHM De Mulder, ... Annals of oncology 5 (6), 521-526, 1994 | 346 | 1994 |
| Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a phase III study of the European Organization for … PE Postmus, H Haaxma-Reiche, EF Smit, HJM Groen, H Karnicka, ... Journal of clinical oncology 18 (19), 3400-3408, 2000 | 291 | 2000 |
| Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study M Tettamanti, U Lucca, F Gandini, A Recchia, P Mosconi, G Apolone, ... haematologica 95 (11), 1849, 2010 | 283 | 2010 |
| Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer … G Giaccone, A Ardizzoni, A Kirkpatrick, M Clerico, T Sahmoud, ... Journal of clinical oncology 14 (3), 814-820, 1996 | 262 | 1996 |
| Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian … F Cognetti, EM Ruggeri, A Felici, M Gallucci, G Muto, CF Pollera, ... Annals of oncology 23 (3), 695-700, 2012 | 251 | 2012 |
| Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the “Health and Anemia” study U Lucca, M Tettamanti, P Mosconi, G Apolone, F Gandini, A Nobili, ... PloS one 3 (4), e1920, 2008 | 207 | 2008 |
| Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study E Riva, M Tettamanti, P Mosconi, G Apolone, F Gandini, A Nobili, ... haematologica 94 (1), 22, 2009 | 188 | 2009 |
| Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial M Colleoni, W Luo, P Karlsson, J Chirgwin, S Aebi, G Jerusalem, P Neven, ... The lancet oncology 19 (1), 127-138, 2018 | 114 | 2018 |
| Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey A Indini, C Aschele, L Cavanna, M Clerico, B Daniele, G Fiorentini, ... European Journal of Cancer 132, 17-23, 2020 | 110 | 2020 |
| Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected … M Ruggeri, E Pagan, V Bagnardi, N Bianco, E Gallerani, K Buser, ... The breast 47, 85-92, 2019 | 108 | 2019 |
| Italian nivolumab expanded access program in nonsquamous non–small cell lung cancer patients: results in never-smokers and EGFR-mutant patients MC Garassino, AJ Gelibter, F Grossi, R Chiari, HS Parra, S Cascinu, ... Journal of Thoracic Oncology 13 (8), 1146-1155, 2018 | 86 | 2018 |
| Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial S De Placido, C Gallo, M De Laurentiis, G Bisagni, G Arpino, MG Sarobba, ... The Lancet Oncology 19 (4), 474-485, 2018 | 85 | 2018 |
| Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme U De Giorgi, G Cartenì, D Giannarelli, U Basso, L Galli, E Cortesi, ... BJU international 123 (1), 98-105, 2019 | 78 | 2019 |
| The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study A Dal Molin, L Rasero, L Guerretta, E Perfetti, M Clerico European Journal of Oncology Nursing 15 (5), 377-381, 2011 | 74 | 2011 |
| Efficacy and skin toxicity management with cetuximab in metastatic colorectal cancer: outcomes from an oncologic/dermatologic cooperation P Racca, L Fanchini, V Caliendo, G Ritorto, W Evangelista, R Volpatto, ... Clinical colorectal cancer 7 (1), 48-54, 2008 | 56 | 2008 |
| Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors F Montagnani, F Crivelli, G Aprile, C Vivaldi, I Pecora, R De Vivo, ... Cancer treatment reviews 69, 11-20, 2018 | 55 | 2018 |
| Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial A Dal Molin, M Clerico, M Baccini, L Guerretta, B Sartorello, L Rasero European Journal of Oncology Nursing 19 (6), 638-643, 2015 | 55 | 2015 |
| Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable … S Guadagni, KR Aigner, G Palumbo, M Cantore, G Fiorentini, T Pozone, ... The Journal of Clinical Pharmacology 38 (10), 936-944, 1998 | 47 | 1998 |
| Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis F Roila, E Cortesi Journal of Clinical Oncology 16 (9), 2937-2942, 1998 | 47 | 1998 |
| Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis F Roila Annals of Oncology 6 (8), 805-810, 1995 | 43 | 1995 |
